Promising Results Shown For Kidney Cancer Drug, Temple University Study
2/4/2010 11:48:03 AM
EurekAlert! -- The drug pazopanib (Votrient) slowed the progression of advanced renal cell carcinoma (RCC), a form of kidney cancer, in patients by 54% percent, according to a new study published in the Journal of Clinical Oncology.
comments powered by